
Indiglobal Labs Private Limited
About Indiglobal Labs Private Limited
Data last updated:
Indiglobal Labs Private Limited is a private limited company based in Hyderabad, Telangana, India, recognised as a startup by DPIIT. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 25 June 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U85100TG2021PTC152547.
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹2.75 Cr. It is led by directors including Sambasiva Rao Puram and Basava Subbarao Nallamekala.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 7 Cf Area Phase – II Ida Cherlapally, Hyderabad, Telangana, India – 500051.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.62 Cr, a decline of 15% compared to the previous year. For the same year it recorded a net loss of ₹97.67 Lakh (net margin -60.1%) and EBITDA of -₹71.71 Lakh (EBITDA margin -44.1%).
The company has about 7 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: IndiGlobal Labs.
Indiglobal Labs Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0018486). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Indiglobal Labs
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-20-0018486
Contact details
Indiglobal Labs Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressPlot No. 7 Cf Area Phase – II Ida Cherlapally, Hyderabad, Telangana, India – 500051
- IndustryPharma, Pharma Contract R&D
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Indiglobal Labs operates one associated brand: IndiGlobal Labs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers clinical research, bioanalytical services, and diagnostics for pharmaceuticals and patients. | indigloballabs.com |
Business activity
The main business activity of Indiglobal Labs is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Indiglobal Labs Private Limited, buy the company report.
Financials of Indiglobal Labs Private Limited
FY 2025 filings availableIndiglobal Labs Private Limited reported revenue of ₹1.62 Cr (down 15% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 15% in the latest year. EBITDA fell 57% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹71.71 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹97.67 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -44.1% | |||
| Net Profit Margin | -60.1% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Indiglobal Labs Private Limited, buy the company report.
Board of directors of Indiglobal Labs Private Limited
Indiglobal Labs has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sambasiva Rao Puram | Director | 25 Jun 2021 | 5 Years 4 Months | Current |
| Basava Subbarao Nallamekala | Director | 25 Jun 2021 | 5 Years 4 Months | Current |
| Venkateswrarao Kanagala | Director | 25 Jun 2021 | 5 Years 4 Months | Current |
Legal cases
No court or tribunal cases involving Indiglobal Labs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Indiglobal Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Indiglobal Labs Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Indiglobal Labs Private Limited has 3 board changes on record since 2021: 3 appointments. The latest: Basava Subbarao Nallamekala was appointed as Director on 25 Jun 2021.
Frequently asked questions
Indiglobal Labs is an active private limited company based in Hyderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 25 June 2021 (5+ years old) and is registered under CIN U85100TG2021PTC152547.
Indiglobal Labs has 3 current directors:
- Sambasiva Rao Puram - Director
- Basava Subbarao Nallamekala - Director
- Venkateswrarao Kanagala - Director
The latest financial statements of Indiglobal Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Indiglobal Labs is U85100TG2021PTC152547. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Indiglobal Labs was incorporated on 25 June 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.
Basava Subbarao Nallamekala was appointed as Director on 25 Jun 2021. Sambasiva Rao Puram was appointed as Director on 25 Jun 2021. Venkateswrarao Kanagala was appointed as Director on 25 Jun 2021.
Yes, Indiglobal Labs is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Indiglobal Labs is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-20-0018486).
The registered office of Indiglobal Labs is at Plot No. 7 Cf Area Phase – II Ida Cherlapally, Hyderabad, Telangana, India – 500051.
Indiglobal Labs operates in the pharma industry, in the pharma contract r and d segment.